Trial Profile
Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Azelaic acid (Primary) ; Brimonidine
- Indications Rosacea
- Focus Therapeutic Use
- 29 Sep 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 15 Feb 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 15 Feb 2015 Planned End Date changed from 1 Oct 2014 to 1 Oct 2015 as reported by ClinicalTrials.gov record.